Bugs and drugs: Predicting response to therapy
نویسندگان
چکیده
منابع مشابه
Predicting response to herceptin therapy.
The activation of cellular oncogenes plays an important role in the development of cancer. An important member of the oncogene family is the growth factor receptor known as the human epidermal growth factor receptor-2 (HER-2), which is also referred to as HER-2/neu or c-erbB-2. The HER-2/neu oncogene has been localized to chromosome 17q and encodes a transmembrane tyrosine kinase that is expres...
متن کاملPredicting response to epigenetic therapy.
Drugs targeting the epigenome are new promising cancer treatment modalities; however, not all patients receive the same benefit from these drugs. In contrast to conventional chemotherapy, responses may take several months after the initiation of treatment to occur. Accordingly, identification of good pretreatment predictors of response is of great value. Many clinical parameters and molecular t...
متن کاملPredicting Bugs from History
Version and bug databases contain a wealth of information about software failures—how the failure occurred, who was affected, and how it was fixed. Such defect information can be automatically mined from software archives; and it frequently turns out that some modules are far more defect-prone than others. How do these differences come to be? We research how code properties like (a) code comple...
متن کاملPredicting Effort to Fix Software Bugs
Predicting the time and effort for a software problem has long been a difficult task. We present an approach that predicts the fixing effort for an issue. Our technique leverages existing issue tracking systems: given a new issue report, we search for similar, earlier reports and use their average time as a prediction. Our approach thus allows for early effort estimation, helping in assigning i...
متن کاملPredicting response to hepatitis C therapy.
Current treatment for chronic hepatitis C is expensive, is often accompanied by burdensome side effects, and, sadly, fails in almost half of cases. The ability to predict such failures prior to treatment could save a great deal of pain and expense for the patient with HCV. In this issue of the JCI, Aurora and colleagues describe the development of genetic markers predictive of treatment respons...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Gastroenterology and Hepatology
سال: 2018
ISSN: 0815-9319
DOI: 10.1111/jgh.14432